M
2.62
0.05 (1.99%)
Previous Close | 2.57 |
Open | 2.59 |
Volume | 128,872 |
Avg. Volume (3M) | 174,373 |
Market Cap | 13,547,941 |
Price / Sales | 8.26 |
Price / Book | 0.950 |
52 Weeks Range |
Operating Margin (TTM) | -2,264.62% |
Diluted EPS (TTM) | -4.84 |
Quarterly Revenue Growth (YOY) | -56.90% |
Total Debt/Equity (MRQ) | 1.54% |
Current Ratio (MRQ) | 0.050 |
Operating Cash Flow (TTM) | -4.86 M |
Levered Free Cash Flow (TTM) | -1.09 M |
Return on Assets (TTM) | -62.72% |
Return on Equity (TTM) | -118.31% |
Market Trend
Short Term | Medium Term | ||
Industry | Health Information Services (US) | Bearish | Bearish |
Health Information Services (Global) | Bearish | Bearish | |
Stock | Mangoceuticals, Inc. | - | - |
AIStockmoo Score
-1.3
Analyst Consensus | -2.0 |
Insider Activity | 1.5 |
Price Volatility | -2.0 |
Technical Moving Averages | 0.0 |
Technical Oscillators | -4.0 |
Average | -1.30 |
Mangoceuticals Inc focuses on developing, marketing, and selling a variety of men’s wellness products and services through a telemedicine platform. The platform provides access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations, including Mango ED products. |
|
Sector | Healthcare |
Industry | Health Information Services |
% Held by Insiders | 34.89% |
% Held by Institutions | 1.48% |
Ownership
Name | Date | Shares Held |
---|---|---|
Ackerman Capital Advisors, Llc | 31 Dec 2024 | 34,500 |
Mccollum Christoferson Group Llc | 31 Dec 2024 | 0 |
No data within this time range.
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
Realized Profit | - |
Unrealized Profit | - |
Dividend Received 2025 | - |
Total Profit | - |
Avg. Return | - |
Quantity (Buy) | - |
Avg. Price (Buy) | - |
Quantity (Sold) | - |
Avg. Price (Sold) | - |